Coming Soon: ITUS launches CAR-T drug development program against Ovarian Cancer.

Learn More

ITUS Corporation is developing a platform called Cchek™, a series of inexpensive non-invasive blood tests for the early detection of cancer.

Logo Check

October 2015

Initial biomarker results for breast cancer

February 2016

Christiana Care joins biomarker study

April 2016

Efficacy shown for lung cancer

July 2016

Virtua Healthcare joins biomarker study

September 2016

Efficacy shown for melanoma, colon and ovarian cancers

October 2016

Efficacy shown for liver, thyroid, and pancreatic cancers

November 2016

Efficacy shown for 6 additional cancer types

December 2016

Preliminary cancer patient study results announced

December 2016

MD Anderson Cooper joins biomarker study

In Progress

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

ITUS Corporation Announces First Commercial Focus for Cchek™ will be Prostate Cancer


ITUS Corporation to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and ReedSmith


ITUS Presentation to Special Meeting of Stockholders


Stock Data

View Investors Relations
Nasdaq: ITUS

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.